Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis [Phase 3]
A Phase 3 open-label study evaluating the safety and efficacy of AK101 injections for plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 study of SYHX1901 tablets for moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy [Phase 4]
A Phase 4 head-to-head clinical trial comparing subcutaneous risankizumab to oral apremilast in adults with moderate plaque psoriasis; the t…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea [Phase 3]
A Phase 3 study of brodalumab (KHK4827) for moderate to severe plaque psoriasis in Korea has been completed.
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Combination of Sotyktu and Enstilar for Plaque Psoriasis [Phase 4]
Phase 4 clinical trial evaluating the combination of Sotyktu and Enstilar for plaque psoriasis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 study update reporting efficacy and safety results of bimekizumab in adult Korean participants with moderate to severe plaque psor…
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO [Phase 3]
Phase III study update for a recombinant anti-IL-17A monoclonal antibody in Chinese patients with plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis [Phase 3]
Phase 3 trial results (efficacy and safety) for brodalumab in adolescents aged 12 to 17 with moderate-to-severe plaque psoriasis; the study …
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial comparing ABP 501 with Humira in moderate to severe plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD) [Phase 3]
Phase 3 trial evaluating Secukinumab for plaque psoriasis with coexisting NAFLD was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial comparing subcutaneous DMB-3115 to Stelara in moderate to severe chronic plaque psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab [Phase 4]
A Phase 4 trial comparing brodalumab with guselkumab in plaque psoriasis patients with inadequate response to ustekinumab was terminated, an…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial of ABP 654 for moderate to severe plaque psoriasis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215) [Phase 2]
Phase 2 trial assessing pharmacokinetics and safety of ARQ-151 in children with plaque psoriasis completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 study evaluating efficacy and safety of apremilast in children aged 6 to 17 with moderate to severe plaque psoriasis is completed. R…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira® [Phase 3]
Phase 3 trial evaluating the efficacy, safety, and immunogenicity of adalimumab compared with Humira in plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis [Phase 4]
Phase 4 trial update on the combination of halobetasol propionate and tazarotene lotion (Duobrii) for palmoplantar plaque-type psoriasis, wi…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 trial of NDI-034858 in moderate to severe plaque psoriasis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: Safety and Tolerability of Repeat Courses of IM Alefacept [Phase 3]
Phase 3 trial update on safety and tolerability of repeat courses of IM Alefacept in chronic plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis [Phase 1, Phase 2]
Clinical trial update for SHR-1314 in moderate-to-severe plaque psoriasis, across Phase 1 and Phase 2, and the study is completed.
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 comparative study of BAT2206 versus Stelara® in moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis [Phase 4]
Phase 4 trial updating Adrenal suppression and absorption of halobetasol propionate foam in adolescents with plaque psoriasis; results poste…
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis [Phase 2]
A Phase 2 clinical trial evaluating ABY-035 in subjects with moderate-to-severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital. [Phase 4]
A Phase 4 clinical trial evaluating the outcome of secukinumab treatment in moderate to severe plaque psoriasis completed at a tertiary care…
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis [Phase 3]
A Phase 3 trial comparing CT-P43 to Stelara in patients with plaque psoriasis has completed with results posted.